The Official Journal of the Turkish Society Of Clinical Microbiology and Infectious Diseases (KLİMİK)

Infectious Diseases

Filter Newest Oldest Showing 1-20 of 27 results
Review Article / VOLUME 6, ISSUE 2, JUNE 2024

Discontinuation of Nucleos(t)ide Analogues in HBeAg Negative Chronic Hepatitis B Patients: Risks and Benefits

Pınar Korkmaz and Neşe Demirtürk

Chronic hepatitis B (CHB) remains a major threat to global public health, affecting 296 million people worldwide. CHB increases the risk of cirrhosis, liver failure and hepatocellular carcinoma, causing liver-related morbidity and mortality. All these risks can be prevented with antiviral treatment. Although there is no curative treatment for CHB today the virus can be effectively controlled with existing (...) Read More

Original Article / VOLUME 6, ISSUE 2, JUNE 2024

COVID-19 Vaccines and COVID-19 in People Living with HIV

Muhammed Fatih Karaşın and others

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a strain of the coronavirus that causes COVID-19, spread rapidly around the world and was defined as a pandemic on March 12, 2020, by the World Health Organization. As of June 2023, more than 767 million cases were confirmed globally, along with 6.9 million deaths. Read More

Original Article / VOLUME 6, ISSUE 2, JUNE 2024

The Impact of Reporting the Same-Day Identification and Antibiotic Susceptibility Test Results on the Treatment of Bloodstream Infections

Mervenur Demir and others

The global increase in the rate of multi-drug resistant (MDR) bacterial infections in recent years is an important public health problem that limits the therapeutic options. The issue becomes particularly critical in cases of bloodstream infections (BSI) in which delay is associated with high mortality rates. Bacteria grown in blood cultures (BC) must be subcultured on the solid media (...) Read More

Correspondence / VOLUME 6, ISSUE 2, JUNE 2024

ChatGPT as a Novel Consultant in Infectious Diseases and Clinical Microbiology: Correspondence

Hinpetch Daungsupawong and Viroj Wiwanitkit

Tunçer et al. brought us interesting observations from the study “How Reliable is ChatGPT as a Novel Consultant in Infectious Diseases and Clinical Microbiology?”. In conclusion, 200 questions about infectious diseases from different platforms were used in the study, along with recommendations from reliable sources. The replies were predicated on (...) Read More

Review Article / VOLUME 5, ISSUE 4, DECEMBER 2023

Is There a Role for Dark Field Microscopy in the Diagnosis of Lyme Disease?
A Narrative Review

Uğur Önal and others

Lyme disease, also known as Lyme borreliosis, is the most common vector-borne disease in Europe and North America, caused by the spirochete Borrelia species, which can be transmitted through the bite of an infected black-legged tick. The Centers for Disease Control and Prevention (CDC) data on Lyme disease in the United States showed (...) Read More

Original Article / VOLUME 5, ISSUE 4, DECEMBER 2023

Brucellar Epididymo-Orchitis in a Brucellosis Hyperendemic Region in Türkiye

Hatun Öztürk-Çerik and others

Brucellosis is a widespread zoonosis transmitted to humans, mainly through direct or indirect contact with infected animals. The main endemic areas are the Mediterranean region, Middle East, Central Asia, China, India, sub-Saharan Africa, and Central and South America. Brucellosis is a systemic infection with a broad clinical spectrum (...) Read More

Case Report / VOLUME 5, ISSUE 4, DECEMBER 2023

Clinical Entity Mimicking Infectious Cellulitis: Eosinophilic Cellulitis (Wells’ Syndrome)

Mustafa Deniz and others

Eosinophilic cellulitis (EC) is a rare inflammatory skin condition with fewer than 200 documented cases in the medical literature. There are only a limited number of case reports available from our country. The prevalence and incidence of EC are unknown. The disease is characterized by pruritic, non-purulent, erythematous plaques (...) Read More

Original Article / VOLUME 5, ISSUE 3, SEPTEMBER 2023

Bibliometric Analysis of the Publications on Middle East Respiratory Syndrome Coronavirus Published Between 2012-2022

Sevil Alkan and Esra Gürbüz

Middle East Respiratory Syndrome (MERS) is a viral respiratory infection caused by the MERS coronavirus (MERS-CoV) from the Coronaviridae family. MERS coronavirus was first identified as the etiologic agent from a patient living in Saudi Arabia in 2012, and it is the sixth human coronavirus . After the first case, the infection was detected in Bahrain, Iran, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, the United Arab Emirates, and Yemen. So far, all MERS-CoV cases worldwide have been associated with a travel history (...) Read More

Original Article / VOLUME 5, ISSUE 1, MARCH 2023

Evaluation of Inflammation-Based Prognostic Risk Scores in Predicting in-Hospital Mortality Risk in COVID-19 Patients: A Cross-Sectional Retrospective Study

Çaşıt Olgun Çelik and others

An acute respiratory syndrome (COVID-19), caused by a novel coronavirus (SARS-CoV-2), has spread from China worldwide and caused a pandemic that brought severe medical, social, and economic problems. The COVID-19 infection results in various clinical presentations ranging from an asymptomatic (...) Read More

Original Article / VOLUME 5, ISSUE 1, MARCH 2023

Fournier’s Gangrene: Microbiological Profile and Risk Factors for Mortality: Review of 97 Cases

Aynur Atilla and others

Fournier’s gangrene (FG) is necrotizing fasciitis of genital or perianal areas. Typically, FG is an infection of polymicrobial origin and has higher mortality rates if treatment is not initiated earlier. The main etiological factors are colorectal (30%-50%) and genitourinary origins (20%-40%), including anorectal infections, (...) Read More

Original Article / VOLUME 5, ISSUE 1, MARCH 2023

Ophthalmologic Examination and Echocardiography Should be the Essential Components of Candidemia Bundle

Çiğdem Erol and others

Candida species are major sources of morbidity and mortality in healthcare settings. These infections are predominantly connected with medical procedures. The five most prevalent pathogens- Candida albicans, Candida glabrata, Candida tropicalis, Candida parapsilosis, and Candida krusei – are responsible for (...) Read More

Case Report / VOLUME 5, ISSUE 1, MARCH 2023

Challenges in Diagnosis and Treatment of Fasciola hepatica Infection

Fatihan Pınarlık and others

Fascioliasis is a neglected tropical disease caused by liver flukes, Fasciola hepatica or Fasciola gigantica, and affects at least 2.4 million people worldwide, according to World Health Organization (WHO) estimates (1). Sheep and cattle are the natural definitive hosts of F. hepatica infection; therefore, fascioliasis is common in sheep-raising (...) Read More

Case Report / VOLUME 5, ISSUE 1, MARCH 2023

Four Human Mpox Cases from Turkey

Emine Coşkun and others

With the reports of patients with mpox (formerly monkeypox) outside Africa in April 2022, a second epidemic fear emerged around the world following the coronavirus disease 2019. From the onset of the mpox outbreak as of December 25, 2022, (...) Read More

Commentary / VOLUME 5, ISSUE 1, MARCH 2023

An Update on the Imported Cutaneous Leishmaniasis in Europe

Özgür Kurt and others

The refugee crisis is one of the leading problems of the world today. Factors such as political unrest and wars, drought and famine associated with global warming, and overcrowded neighborhoods after the influx of refugees may seriously aggravate this problem. According to the United Nations Refugee Committee, there are almost 27 million refugees in the world today; Syria, Venezuela, and (...) Read More